Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)

  • G Bug
  • A Burchert
  • E-M Wagner
  • N Kröger
  • T Berg
  • S Güller
  • S K Metzelder
  • A Wolf
  • S Hünecke
  • P Bader
  • J Schetelig
  • H Serve
  • O G Ottmann

Bibliographical data

Original languageEnglish
ISSN0887-6924
DOIs
Publication statusPublished - 11.2017

Comment Deanary

Letter

PubMed 28751769